Clinical Trial Update: A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating TQB3473 tablets versus placebo in adults with Primary Immune Thrombocytopenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• TQB3473

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Primary Immune Thrombocytopenia | Phase 3 | Status: RECRUITING